Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenic Escherichia coli.

James B Kaper1, James P Nataro, Harry L Mobley

  • 1Center for Vaccine Development, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. jkaper@umaryland.edu

Nature Reviews. Microbiology
|March 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'The Environmental Enteric Dysfunction Biopsy Initiative (EEDBI) Consortium: mucosal investigations of EED' [The American Journal of Clinical Nutrition. 2024; 120S1: S4-S14].

The American journal of clinical nutrition·2026
Same author

A history of <i>EcoSal Plus</i>.

EcoSal Plus·2025
Same author

Whole-genome analysis of rotavirus G1P[8] and other Wa-like strains in Mozambican children: evidence of genetic variations of pre-vaccine G1P[8] strains from Manhiça, Mozambique.

Microbial genomics·2025
Same author

CD45-mediated apoptosis and IL-2 receptor downregulation by serine proteases secreted from diarrheagenic bacteria.

bioRxiv : the preprint server for biology·2025
Same author

Genomic analysis of DS-1-like human rotavirus A strains uncovers genetic relatedness of NSP4 gene with animal strains in Manhiça District, Southern Mozambique.

Scientific reports·2024
Same author

The Environmental Enteric Dysfunction Biopsy Initiative (EEDBI) Consortium: mucosal investigations of environmental enteric dysfunction.

The American journal of clinical nutrition·2024

Escherichia coli (E. coli) is a versatile bacterium, known as both a gut microbe and a lab tool. However, specific E. coli strains are dangerous pathogens causing various diseases through potent virulence factors.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pathogenesis

Background:

  • Escherichia coli (E. coli) is a common bacterium found in the intestines of humans and mammals.
  • It is widely utilized in molecular biology as a host for recombinant DNA technology.
  • Beyond its commensal and laboratory roles, E. coli can act as a significant pathogen.

Purpose of the Study:

  • To highlight the multifaceted nature of Escherichia coli.
  • To underscore its transition from a harmless inhabitant to a dangerous pathogen.
  • To introduce the concept of diverse E. coli strains causing varied diseases.

Main Methods:

  • Review of existing literature on E. coli.
  • Analysis of E. coli's roles in intestinal microflora.

Related Experiment Videos

  • Examination of E. coli's applications in recombinant DNA technology.
  • Investigation of pathogenic E. coli strains and their mechanisms.

    • Main Results:

    • E. coli exhibits remarkable versatility, serving as a commensal organism, a molecular biology workhorse, and a pathogen.
    • Pathogenic E. coli strains are responsible for a spectrum of intestinal and extraintestinal diseases.
    • Virulence factors employed by pathogenic E. coli target a broad array of cellular processes.

    Conclusions:

    • Escherichia coli possesses a dual nature, being both beneficial/neutral and pathogenic.
    • Understanding the virulence factors of pathogenic E. coli is crucial for addressing associated diseases.
    • The adaptability of E. coli contributes to its diverse roles in health and disease.